MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Inspire Medical Systems Inc

Chiusa

SettoreSettore sanitario

98.32 1.34

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

96.14

Massimo

99.16

Metriche Chiave

By Trading Economics

Entrata

14M

9.9M

Vendite

7.4M

225M

P/E

Media del settore

64.904

87.826

Margine di Profitto

4.424

Dipendenti

1,246

EBITDA

16M

17M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+49.48% upside

Dividendi

By Dow Jones

Utili prossimi

11 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

623M

2.8B

Apertura precedente

96.98

Chiusura precedente

98.32

Notizie sul Sentiment di mercato

By Acuity

50%

50%

166 / 372 Classifica in Healthcare

Inspire Medical Systems Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2026, 23:11 UTC

Utili

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 gen 2026, 22:55 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 gen 2026, 21:39 UTC

I principali Market Mover

Raytheon Down Following Trump Post Criticizing Company

7 gen 2026, 20:13 UTC

I principali Market Mover

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 gen 2026, 20:03 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 gen 2026, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 gen 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 gen 2026, 22:48 UTC

Discorsi di Mercato

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 gen 2026, 22:46 UTC

Utili

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 gen 2026, 22:45 UTC

Utili

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 gen 2026, 22:42 UTC

Utili

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 gen 2026, 22:40 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 gen 2026, 22:31 UTC

Discorsi di Mercato

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 gen 2026, 22:22 UTC

Discorsi di Mercato

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 gen 2026, 22:01 UTC

Discorsi di Mercato

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 gen 2026, 21:46 UTC

Discorsi di Mercato

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 gen 2026, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 gen 2026, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 gen 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 gen 2026, 20:29 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 gen 2026, 20:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 gen 2026, 19:58 UTC

Discorsi di Mercato

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 gen 2026, 19:48 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Confronto tra pari

Modifica del prezzo

Inspire Medical Systems Inc Previsione

Obiettivo di Prezzo

By TipRanks

49.48% in crescita

Previsioni per 12 mesi

Media 145.31 USD  49.48%

Alto 180 USD

Basso 91 USD

Basato su 19 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Inspire Medical Systems Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

19 ratings

13

Acquista

6

Mantieni

0

Vendi

Sentiment

By Acuity

166 / 372 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat